Navigation Links
Refractory Hematological Malignancies (MDS, AML) Market Emerging Therapeutics Analysis Available at

Dallas, Texas (PRWEB) September 01, 2013

The report provides an overview of the approved therapies for AML, MDS, unmet need and limitations of the current SOC for relapsed and refractory pts. The report highlights the competition and commercial opportunity in pursuing this therapy area – Comprehensive list of the early and late stage drugs in the clinic, their MoA and the companies developing them.

Detailed financial and competitive analysis of the companies leading in the race to launch new therapies for this indication – Ambit Biosciences, Onconova Therapeutics, SymBio Pharma, and Celgene are available as a separate or with the full report. Key M&A activities that have taken place in this area in the last five years and a list of products in early /late stages of development available for in-licensing are highlighted in the report. This report is built using primary and secondary research data and in-house proprietary database.

Get a copy of the complete report with comprehensive Table of Contents @

Reasons to buy the report :
Useful for investors, Scientists, Business development managers of Pharma companies with a focus in oncology to address the following-

  •     What are the opportunities or new approaches to be deployed in the R&D of the company?
  •     List of validated and new targets
  •     In-licensing opportunities – Is the way to go forward and be in the race?
  •     Commercial opportunity and companies’ valuation.

Key Points Discussed in the Report –
1.    Overview of the disease and Unmet need
2.    Drugs in the pipeline – Mechanism of Action (MoA) and Clinical Stage of development
a.    Myelodysplastic Syndromes – Lower-risk, Higher-risk, and recurrent / refractory MDS
b.    Acute Myeloid Leukemia – Untreated/ newly diagnosed and relapsed / refractory AML
3.    Key milestones
4.    Launch Timeline and Commercial Opportunity of Late-stage pipeline (RR MDS and RR AML)
5.    M&A and Licensing deals in the last 5 years
6.    In-licensing and/or M&A Opportunity
7.    Detailed Company analysis includes Clinical data of drugs , Milestones and Valuation for Ambit Biosciences (AMBI), Onconova Therapeutics (ONTX), Celgene (CELG) and SymBio (4582).

Place a direct purchase order @
Alternatively inquire for discount @

Explore above and other reports by MP Advisors @

About Us: is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. We provide 24/7 online and offline support service to our customers. Our database includes reports by leading publishers from across the globe. We also offer custom research services in case your requirements are not covered in the available syndicated market research reports in our database.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
2. Effects of alcohol on lymphoma, leukemia, and other types of hematological cancers
3. N-Butanol Market (Butyl Acrylate, Butyl Acetate, Glycol Ethers) worth $9.4 Billion by 2018 - New Report by MarketsandMarkets
4. Global Proteomics Market (Instrumentation Technology, Reagents & Services) Worth $17.2 Billion by 2017 - New Report by MarketsandMarkets
5. The Global Ophthalmology Devices and Drugs Market is Expected to Reach $52.6 Billion by 2017 - New Report by MarketsandMarkets
6. Contrast Media / Contrast Agents Market (Interventional Radiology & Interventional Cardiology) worth $8.6 Billion by 2017 - New Report by MarketsandMarkets
7. Transformer Oil Market (Mineral Oil - Naphthenic & Paraffinic) Worth $2.46 Billion by 2017 - New Report by MarketsandMarkets
8. Therapeutic Partnering Market Trends with 2013 Analysis in New Research Report at
9. Telerad Tech's RADSpa™ Announces Its Entry Into Brazil Markets
10. Flight Management Systems Market (Flight Management Computer, Flight Management Control Unit) Worth $1.8 Billion By 2018 – New Report by MarketsandMarkets
11. Slimming Kou Tea: The Newest Weight Loss Tea Released in the Market With 1 Month Extra Supply
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by ... of issues that are presently affecting Americans. Dedicated to providing the world with a ... the subjects consumers focus on, one episode at a time. , In the ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to announce ... (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored to ... of twelve colleges and universities in the state of California make the cut. CBD ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  The total global healthcare industry is expected to grow ... Latin America has the highest projected growth at ... Japan ), is second with growth projected at 11.5%. ... healthcare expenditure. In 2013-2014, total government funded healthcare was nearly ... to 41.2% in 2013-2014. In real terms, out of pocket ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... Nov. 25, 2015 AAIPharma Services Corp./Cambridge ... of at least $15.8  Million to expand its ... NC . The expansion will provide additional ... the growing demands of the pharmaceutical and biotechnology ... expansion will provide up to 40,000 square feet ...
Breaking Medicine Technology: